Pharmafile Logo

Cuttsy+Cuttsy and ISPEP highlight key patient insights in new clinical trials report

Explore how Cuttsy+Cuttsy and ISPEP are spotlighting patient engagement in clinical trials through a new global report.

Upcoming report announcement

Cuttsy+Cuttsy, the original patient communications agency, in partnership with the International Society for Patient Engagement Professionals (ISPEP), is proud to announce the upcoming release of their latest report, offering a 360-degree view into patient engagement in clinical trials, both at recruitment stage and during their time participating in a trial.

Based on extensive global research with over 700 clinical trial patients, as well as insights from the specialist Cuttsy+Cuttsy team alongside industry leaders, the report provides a comprehensive analysis of patient experiences. It sheds light on their motivations, emotional and psychological responses, effectiveness of support materials, and need for clear communication during clinical trials. By gathering feedback from an international audience, the findings offer actionable strategies to enhance patient satisfaction, trial completion rates, and overall study success on a global stage.

“Too often, the patient voice is acknowledged in theory but overlooked in practice,” said Caroline Benson, Co-Founder of Cuttsy+Cuttsy. “This report is about more than metrics; it’s about truly listening to what patients experience and need. When we design trials around real people, not just protocols, everyone wins.”

Alongside ISPEP’s aim to amplify the patient voice across medicine development, this report exemplifies Cuttsy+Cuttsy’s mission to empower the healthcare industry with data-driven tools that advance patient-centric approaches to clinical research.

Request a copy of the new report.

This content was provided by Cuttsy + Cuttsy

Company Details

 Latest Content from  Cuttsy + Cuttsy 

New report now available: Integrating ‘patient first’ into medicine development

A new report has just been published by Cuttsy+Cuttsy that collates all the current best thinking in the ‘patient first’ space, distilling it into a practical and actionable road map...

The digital prescription – enhancing the patient experience with technology

We explore how digital health innovations are revolutionising patient care by enhancing accessibility, personalisation, and engagement, promising a more connected and empowered patient experience.

Compliance — a driving force for influencing public perceptions of the pharma industry?

How does compliance play into public perceptions of pharma and why is it important for improving public opinion?

Another year, another B!

Louise Jones, Cuttsy+Cuttsy's Sustainability Officer reflects on their latest year of carbon reporting through CDP and on achieving another B rating.

Jon Hume Joins Cuttsy+Cuttsy as New Commercial Director

Cuttsy+Cuttsy is excited to announce the appointment of Jon Hume as Commercial Director, effective 1st March 2024.

Clinical trial considerations: Why supporting HCPs matters…

When HCPs have the necessary information, they can more easily communicate it to patients using simplified language and a confident, calm tone.

Clinical trial considerations: Why diversity matters…

Diversity in clinical trials is crucial for understanding diseases and developing new treatments. Here's why diversity matters...

Clinical trial considerations: Why digital matters…

Digital technology in healthcare is rapidly evolving. In this blog we delve into how digital solutions can help improve patient experience within clinical trials.

Clinical trials explained: Why imagery matters…

Recruiting patients for clinical trials is one of pharma's greatest challenges. Imagery is a great way to connect with people on an emotional level and forms a big part the...

Clinical trials explained: Why health literacy matters…

Clinical trial recruitment can be a challenge. By applying the principles of health literacy to all materials, we can support people to make an informed choice about whether to take...